1263274-67-4Relevant articles and documents
SODIUM ION CHANNEL INHIBITORS AND PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHS THEREOF AND USES THEREOF
-
Page/Page column 0358-0359, (2020/02/27)
The present disclosure discloses sodium ion channel inhibitors, pharmaceutically acceptable salts and polymorphs thereof, and uses thereof. Specifically, the present disclosure discloses a polymorph of a compound of formula (X) and a preparation method th
N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
-
Paragraph 0722; 0723-0724, (2013/12/04)
The invention provides novel compounds having the general formula: and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, B, R1, R2, R3, R4, R5 and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
CHEMICAL COMPOUNDS
-
, (2012/02/02)
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein X, Ar1, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.